Golimumab Completed Phase 4 Trials for Ulcerative Colitis Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03124121 | Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels | |
| NCT02092285 | Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) | |
| NCT02155335 | Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) |